Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...
AUSTIN, Texas — A new program in partnership with Baylor Scott & White Medical Center, Goodwill and the Texas Workforce Commission is helping Austin Independent School District (AISD) students with ...
The Internet has Google. Now biology has MetaGraph. Detailed today in Nature, the search engine can quickly sift through the staggering volumes of biological data housed in public repositories. “It’s ...
This study primarily focuses on analyzing the pore structure characteristics and predicting permeability in binary blended pervious concretes, both with and without fines. The pervious concretes ...
Sept 2 (Reuters) - Google won't have to sell its Chrome browser, a judge in Washington said on Tuesday, handing a rare win to Big Tech in its battle with U.S. antitrust enforcers, but ordering Google ...
Last year, Google introduced “AI Overviews,” a feature that displays an artificial intelligence-generated result summary at the top of many Google search pages. This feature is available to millions ...